These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3117905)

  • 1. Involvement of urokinase-type plasminogen activator in acantholysis induced by pemphigus IgG.
    Morioka S; Lazarus GS; Jensen PJ
    J Invest Dermatol; 1987 Nov; 89(5):474-7. PubMed ID: 3117905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Academy of Dermatology 1999 Awards for Young Investigators in Dermatology. Pemphigus vulgaris IgG regulates expression of urokinase receptor and junctional proteins that may contribute to acantholysis.
    Xue W
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):462-3. PubMed ID: 10507914
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasmin induces acantholysis in skin organ cultures.
    Hunziker T; Vassalli JD
    Arch Dermatol Res; 1987; 279(5):341-6. PubMed ID: 2957965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional involvement of urokinase-type plasminogen activator receptor in pemphigus acantholysis.
    Xue W; Hashimoto K; Toi Y
    J Cutan Pathol; 1998 Oct; 25(9):469-74. PubMed ID: 9821076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor.
    Hashimoto K; Wun TC; Baird J; Lazarus GS; Jensen PJ
    J Invest Dermatol; 1989 Mar; 92(3):310-4. PubMed ID: 2465356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of urokinase-type plasminogen activator in the pathogenesis of pemphigus].
    Nie Z; Liu R; Ye Q
    Zhonghua Yi Xue Za Zhi; 1997 Oct; 77(10):771-3. PubMed ID: 9772525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pemphigus IgG induces expression of urokinase plasminogen activator receptor on the cell surface of cultured keratinocytes.
    Seishima M; Satoh S; Nojiri M; Osada K; Kitajima Y
    J Invest Dermatol; 1997 Nov; 109(5):650-5. PubMed ID: 9347794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of plasminogen activator in pemphigus vulgaris.
    Wilkinson JE; Smith CA; Suter MM; Falchek W; Lewis RM
    Am J Pathol; 1989 Mar; 134(3):561-9. PubMed ID: 2466403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis.
    Anhalt GJ; Patel HP; Labib RS; Diaz LA; Proud D
    J Immunol; 1986 Jan; 136(1):113-7. PubMed ID: 3079604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro studies of acantholysis of keratinocytes induced by pemphigus antibody.
    Hashimoto KH; Jensen PJ; Lazarus GS; Morioka S; Singer KH
    Immunol Ser; 1989; 46():277-90. PubMed ID: 2535130
    [No Abstract]   [Full Text] [Related]  

  • 11. Protease inhibitors prevent plasminogen-mediated, but not pemphigus vulgaris-induced, acantholysis in human epidermis.
    Schuh T; Besch R; Braungart E; Flaig MJ; Douwes K; Sander CA; Magdolen V; Probst C; Wosikowski K; Degitz K
    Biol Chem; 2003 Feb; 384(2):311-5. PubMed ID: 12675525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation.
    Hashimoto K; Shafran KM; Webber PS; Lazarus GS; Singer KH
    J Exp Med; 1983 Jan; 157(1):259-72. PubMed ID: 6681540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appearance of "pemphigus acantholysis factor" in human skin cultured with pemphigus antibody.
    Schiltz JR; Michel B; Papay R
    J Invest Dermatol; 1979 Dec; 73(6):575-81. PubMed ID: 512411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenic role of pemphigus antibodies and proteinase in epidermal acantholysis.
    Morioka S; Naito K; Ogawa H
    J Invest Dermatol; 1981 May; 76(5):337-41. PubMed ID: 7014725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice.
    Mahoney MG; Wang ZH; Stanley JR
    J Invest Dermatol; 1999 Jul; 113(1):22-5. PubMed ID: 10417613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement fixation by pemphigus antibody. IV. Enhanced epidermal cell detachment in the absence of human plasminogen.
    Doubleday CW; Geoghegan WD; Jordon RE
    J Lab Clin Med; 1988 Jan; 111(1):28-34. PubMed ID: 3335823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol-specific-phospholipase C cleaves urokinase plasminogen activator receptor from the cell surface and leads to inhibition of pemphigus-IgG-induced acantholysis in DJM-1 cells, a squamous cell carcinoma line.
    Asano S; Seishima M; Kitajima Y
    Clin Exp Dermatol; 2001 May; 26(3):289-95. PubMed ID: 11422178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo studies of antibody dependent acantholysis.
    Anhalt GJ; Diaz LA
    Immunol Ser; 1989; 46():291-316. PubMed ID: 2518720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase plasminogen activator mRNA is induced by IL-1alpha and TNF-alpha in in vitro acantholysis.
    Feliciani C; Toto P; Wang B; Sauder DN; Amerio P; Tulli A
    Exp Dermatol; 2003 Aug; 12(4):466-71. PubMed ID: 12930304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum.
    Schiltz JR; Michel B
    J Invest Dermatol; 1976 Aug; 67(2):254-60. PubMed ID: 950490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.